Nanjing Pharmaceutical Group Company Limited (SHA:600713)
5.10
+0.07 (1.39%)
Oct 30, 2026, 3:00 PM CST
| Market Cap | 6.67B +0.5% |
| Revenue (ttm) | 55.52B +3.0% |
| Net Income | 638.08M +20.2% |
| EPS | 0.43 +13.6% |
| Shares Out | 1.31B |
| PE Ratio | 11.88 |
| Forward PE | n/a |
| Dividend | 0.18 (3.53%) |
| Ex-Dividend Date | Sep 17, 2026 |
| Volume | 14,763,500 |
| Open | 5.02 |
| Previous Close | 5.03 |
| Day's Range | 4.94 - 5.17 |
| 52-Week Range | 4.78 - 6.65 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |